President Joe Biden announced the launch of a new, $24 million project Wednesday at Emory University in Atlanta, Georgia, aimed at advancing treatments for cancer and other diseases.

The “Curing the Uncurable via RNA-Encoded Immunogene Tuning” program aims to "develop generalizeable mRNA platforms" and marks the first grant awarded by the National Institutes of Health's Advanced Research Projects Agency for Health after being stood up in the spring of 2022.

REPUBLICAN DEBATE: CAN THE DEBATES HELP WINNOW THE GOP FIELD?

"Last year, as part of his Unity Agenda, President Biden worked with Democrats and Republicans in Congress to establish and fund ARPA-H to drive breakthroughs to prevent, detect, and treat cancer and other diseases," the White House said in a statement. "Through CUREIT, ARPA-H is now moving aggressively to deliver on their mission, and to advance the goals of the Biden Cancer Moonshot and the President’s Unity Agenda."

CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER

White House officials say the mRNA research at CUREIT could provide pathways to training human immune systems to "turn off" certain responses, including "prompting immune cells to target and attack tumors."

"Other applications could extend to autoimmune disorders, transplants, and infectious diseases. COVID-19 vaccines developed using mRNA technology platforms have saved millions of lives in the United States and around the world," the White House said. "A toolbox of mRNA platforms offers the potential to transform the fight against cancer and other difficult diseases."